Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$10.4M
-2.2% from 2023
Prescriptions
1,480
$7,031.83 per claim
Patients
236
187 prescribers
Total spending, 2024
$10.4M
$44,097.92 per patient
Medicare prescription drug plans paid $10.4M for Perjeta in 2024, for 1,480 prescriptions and refills to 236 patients (down 2.2% from 2023). The average cost per claim was $7,031.83.
New York had the highest Medicare cost for Perjeta in 2024: $3.0M for 420 claims, followed by California ($2.5M).
Yelda Nouri, hematology-oncology in Riverhead, NY, had the highest Medicare cost for Perjeta in 2024: 29 claims costing $222K.
Perjeta is made by Roche Holding AG (ROG.SW), listed in the Medicare spending data as Genentech, Inc..
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Yelda Nouri Riverhead, NY | Hematology-Oncology | 29 | Under 11 | $222K |
| Javier Ruiz New Windsor, NY | Hematology-Oncology | 30 | Under 11 | $216K |
| Ahmed M Ali Washington, DC |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 174 | 1,386 | 218 | $9.5M |
| 2023 | 169 | 1,440 | 206 | $10.6M |
| 2024 | 187 | 1,480 | 236 | $10.4M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 27 |
| Under 11 |
| $200K |
| Zili He X Flushing, NY | Hematology-Oncology | 28 | Under 11 | $194K |
| Noshir A Dacosta Smithtown, NY | Medical Oncology | 28 | Under 11 | $185K |
| Krisztina I Larson Burbank, CA | Hematology-Oncology | 24 | Under 11 | $179K |
| Songchuan Guo Brooklyn, NY | Hematology-Oncology | 25 | Under 11 | $171K |
| Harsha Vyas Dublin, GA | Internal Medicine | 22 | Under 11 | $144K |
| Fabio Volterra Bronx, NY | Hematology-Oncology | 20 | Under 11 | $141K |
| Matthew M Sochat Goldsboro, NC | Hematology-Oncology | 20 | Under 11 | $137K |
| Adam Hines New Hyde Park, NY | Hematology-Oncology | 18 | Under 11 | $136K |
| Ravin M Rupani Montebello, CA | Hematology-Oncology | 22 | Under 11 | $135K |
| Grace L Raja Little Rock, AR | Hematology-Oncology | 19 | Under 11 | $131K |
| Babak Baseri Cerritos, CA | Hematology-Oncology | 18 | Under 11 | $127K |
| Shahab A Khan Houston, TX | Hematology-Oncology | 16 | Under 11 | $126K |
| Jen Chin Wang Long Beach, NY | Internal Medicine | 18 | Under 11 | $125K |
| Eugenio G Galindo McAllen, TX | Hematology-Oncology | 18 | Under 11 | $125K |
| Arjun Iyengar New York, NY | Hematology-Oncology | 16 | Under 11 | $118K |
| Arnold K Yee Honolulu, HI | Medical Oncology | 18 | Under 11 | $118K |
| Luis G Rangel Hialeah, FL | Hematology-Oncology | 17 | Under 11 | $115K |
| Sridhar P Reddy New York, NY | Hematology-Oncology | 16 | Under 11 | $112K |
| Omar Al Ustwani Vineland, NJ | Hematology-Oncology | 17 | Under 11 | $112K |
| Beaula V Koduri Edison, NJ | Hematology-Oncology | 17 | Under 11 | $112K |
| Gregory L Ortega Orange City, FL | Hematology-Oncology | 17 | Under 11 | $112K |
| Jason S Ho Los Angeles, CA | Hematology-Oncology | 17 | Under 11 | $111K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Genentech, Inc. ROG.SW | 1,480 | $10.4M |